Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis

OBJECTIVES: Mortality and worsening of organ function are desirable endpoints for clinical trials in systemic sclerosis (SSc). The aim of this study was to identify factors that allow enrichment of patients with these endpoints, in a population of patients from the European Scleroderma Trials and Re...

Descripción completa

Detalles Bibliográficos
Autores principales: Becker, Mike, Graf, Nicole, Sauter, Rafael, Allanore, Yannick, Curram, John, Denton, Christopher P, Khanna, Dinesh, Matucci-Cerinic, Marco, de Oliveira Pena, Janethe, Pope, Janet E, Distler, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Systemic Sclerosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788922/
https://www.ncbi.nlm.nih.gov/pubmed/31227488
http://dx.doi.org/10.1136/annrheumdis-2019-215145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788922/
https://www.ncbi.nlm.nih.gov/pubmed/31227488
http://dx.doi.org/10.1136/annrheumdis-2019-215145

Ejemplares similares